PKA Phosphorylates the ATPase Inhibitory Factor 1 and Inactivates Its Capacity to Bind and Inhibit the Mitochondrial H+-ATP Synthase

Cell Reports

Volumn 12, Issue 12, 2015, Pages 2143-2155

  García Bermúdez, Javier ^a,b   Sánchez Aragó, María ^a,b   Soldevilla, Beatriz ^a,b   del Arco, Araceli ^a,b,c   Nuevo Tapioles, Cristina ^a,b   Cuezva, José M ^a,b  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CYCLIC AMP DEPENDENT PROTEIN KINASE; HYDROLASE; PROTEIN IF1; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; REGULATOR PROTEIN; SERINE; SYNTHETASE; UNCLASSIFIED DRUG; ATPASE INHIBITORY PROTEIN; BUCLADESINE; FORSKOLIN; ISOQUINOLINE DERIVATIVE; N-(2-(4-BROMOCINNAMYLAMINO)ETHYL)-5-ISOQUINOLINESULFONAMIDE; PROTEIN; PROTEIN BINDING; SULFONAMIDE;

ANIMAL EXPERIMENT; ARTICLE; BETA ADRENERGIC STIMULATION; CARCINOMA; CELL CYCLE; CELL HYPOXIA; ENERGY METABOLISM; ENZYME ACTIVITY; ENZYME SYNTHESIS; GLYCOLYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; MOUSE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEPHOSPHORYLATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; ANIMAL; BINDING SITE; BIOSYNTHESIS; CARDIAC MUSCLE; CHEMICAL STRUCTURE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; ENZYME ASSAY; GENE EXPRESSION REGULATION; GENETICS; HCT116 CELL LINE; HEART MITOCHONDRION; KINETICS; METABOLISM; PHOSPHORYLATION;

ADENOSINE TRIPHOSPHATE; ANIMALS; BINDING SITES; BUCLADESINE; COLFORSIN; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENZYME ASSAYS; GENE EXPRESSION REGULATION; GLYCOLYSIS; HCT116 CELLS; HUMANS; ISOQUINOLINES; KINETICS; MICE; MITOCHONDRIA, HEART; MITOCHONDRIAL PROTON-TRANSLOCATING ATPASES; MODELS, MOLECULAR; MYOCARDIUM; OXIDATIVE PHOSPHORYLATION; PHOSPHORYLATION; PROTEIN BINDING; PROTEINS; SIGNAL TRANSDUCTION; SULFONAMIDES;

EID: 84942816776     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2015.08.052     Document Type: Article

References (46)

1. Acin-Perez R., Salazar E., Kamenetsky M., Buck J., Levin L.R., Manfredi G. Cyclic AMP produced inside mitochondria regulates oxidative phosphorylation. Cell Metab. 2009, 9:265-276.
2. Acin-Perez R., Gatti D.L., Bai Y., Manfredi G. Protein phosphorylation and prevention of cytochrome oxidase inhibition by ATP: coupled mechanisms of energy metabolism regulation. Cell Metab. 2011, 13:712-719.
3. Acín-Pérez R., Carrascoso I., Baixauli F., Roche-Molina M., Latorre-Pellicer A., Fernández-Silva P., Mittelbrunn M., Sanchez-Madrid F., Pérez-Martos A., Lowell C.A., et al. ROS-triggered phosphorylation of complex II by Fgr kinase regulates cellular adaptation to fuel use. Cell Metab. 2014, 19:1020-1033.
4. Bah A., Vernon R.M., Siddiqui Z., Krzeminski M., Muhandiram R., Zhao C., Sonenberg N., Kay L.E., Forman-Kay J.D. Folding of an intrinsically disordered protein by phosphorylation as a regulatory switch. Nature 2015, 519:106-109.
5. Bason J.V., Montgomery M.G., Leslie A.G., Walker J.E. Pathway of binding of the intrinsically disordered mitochondrial inhibitor protein to F1-ATPase. Proc. Natl. Acad. Sci. USA 2014, 111:11305-11310.
6. Cabezon E., Butler P.J., Runswick M.J., Walker J.E. Modulation of the oligomerization state of the bovine F1-ATPase inhibitor protein, IF1, by pH. J. Biol. Chem. 2000, 275:25460-25464.
7. Cabezón E., Montgomery M.G., Leslie A.G., Walker J.E. The structure of bovine F1-ATPase in complex with its regulatory protein IF1. Nat. Struct. Biol. 2003, 10:744-750.
8. Campanella M., Casswell E., Chong S., Farah Z., Wieckowski M.R., Abramov A.Y., Tinker A., Duchen M.R. Regulation of mitochondrial structure and function by the F1Fo-ATPase inhibitor protein, IF1. Cell Metab. 2008, 8:13-25.
9. Chen Z., Odstrcil E.A., Tu B.P., McKnight S.L. Restriction of DNA replication to the reductive phase of the metabolic cycle protects genome integrity. Science 2007, 316:1916-1919.
10. Chen W.W., Birsoy K., Mihaylova M.M., Snitkin H., Stasinski I., Yucel B., Bayraktar E.C., Carette J.E., Clish C.B., Brummelkamp T.R., et al. Inhibition of ATPIF1 ameliorates severe mitochondrial respiratory chain dysfunction in mammalian cells. Cell Rep. 2014, 7:27-34.
11. Chin R.M., Fu X., Pai M.Y., Vergnes L., Hwang H., Deng G., Diep S., Lomenick B., Meli V.S., Monsalve G.C., et al. The metabolite α-ketoglutarate extends lifespan by inhibiting ATP synthase and TOR. Nature 2014, 510:397-401.
12. Christensen G.L., Kelstrup C.D., Lyngsø C., Sarwar U., Bøgebo R., Sheikh S.P., Gammeltoft S., Olsen J.V., Hansen J.L. Quantitative phosphoproteomics dissection of seven-transmembrane receptor signaling using full and biased agonists. Mol. Cell. Proteomics 2010, 9:1540-1553.
13. Christian D.R., Kilsheimer G.S., Pettett G., Paradise R., Ashmore J. Regulation of lipolysis in cardiac muscle: a system similar to the hormone-sensitive lipase of adipose tissue. Adv. Enzyme Regul. 1969, 7:71-82.
14. Danial N.N., Gramm C.F., Scorrano L., Zhang C.Y., Krauss S., Ranger A.M., Datta S.R., Greenberg M.E., Licklider L.J., Lowell B.B., et al. BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis. Nature 2003, 424:952-956.
15. 2+ uptake induces cyclic AMP generation in the matrix and modulates organelle ATP levels. Cell Metab. 2013, 17:965-975.
16. Di Benedetto G., Pendin D., Greotti E., Pizzo P., Pozzan T. Ca2+ and cAMP cross-talk in mitochondria. J. Physiol. 2014, 592:305-312.
17. Formentini L., Sánchez-Aragó M., Sánchez-Cenizo L., Cuezva J.M. The mitochondrial ATPase inhibitory factor 1 triggers a ROS-mediated retrograde prosurvival and proliferative response. Mol. Cell 2012, 45:731-742.
18. Formentini L., Pereira M.P., Sánchez-Cenizo L., Santacatterina F., Lucas J.J., Navarro C., Martínez-Serrano A., Cuezva J.M. In vivo inhibition of the mitochondrial H+-ATP synthase in neurons promotes metabolic preconditioning. EMBO J. 2014, 33:762-778.
19. Glancy B., Balaban R.S. Role of mitochondrial Ca2+ in the regulation of cellular energetics. Biochemistry 2012, 51:2959-2973.
20. Gledhill J.R., Montgomery M.G., Leslie A.G., Walker J.E. How the regulatory protein, IF(1), inhibits F(1)-ATPase from bovine mitochondria. Proc. Natl. Acad. Sci. USA 2007, 104:15671-15676.
21. Gordon-Smith D.J., Carbajo R.J., Yang J.C., Videler H., Runswick M.J., Walker J.E., Neuhaus D. Solution structure of a C-terminal coiled-coil domain from bovine IF(1): the inhibitor protein of F(1) ATPase. J. Mol. Biol. 2001, 308:325-339.
22. Huang L.J., Durick K., Weiner J.A., Chun J., Taylor S.S. D-AKAP2, a novel protein kinase A anchoring protein with a putative RGS domain. Proc. Natl. Acad. Sci. USA 1997, 94:11184-11189.
23. Kamp T.J., Hell J.W. Regulation of cardiac L-type calcium channels by protein kinase A and protein kinase C. Circ. Res. 2000, 87:1095-1102.
24. Kinoshita E., Kinoshita-Kikuta E., Koike T. Separation and detection of large phosphoproteins using Phos-tag SDS-PAGE. Nat. Protoc. 2009, 4:1513-1521.
25. Livigni A., Scorziello A., Agnese S., Adornetto A., Carlucci A., Garbi C., Castaldo I., Annunziato L., Avvedimento E.V., Feliciello A. Mitochondrial AKAP121 links cAMP and src signaling to oxidative metabolism. Mol. Biol. Cell 2006, 17:263-271.
26. Means C.K., Lygren B., Langeberg L.K., Jain A., Dixon R.E., Vega A.L., Gold M.G., Petrosyan S., Taylor S.S., Murphy A.N., et al. An entirely specific type I A-kinase anchoring protein that can sequester two molecules of protein kinase A at mitochondria. Proc. Natl. Acad. Sci. USA 2011, 108:E1227-E1235.
27. Mourier A., Ruzzenente B., Brandt T., Kühlbrandt W., Larsson N.G. Loss of LRPPRC causes ATP synthase deficiency. Hum. Mol. Genet. 2014, 23:2580-2592.
28. Pagliarini D.J., Dixon J.E. Mitochondrial modulation: reversible phosphorylation takes center stage?. Trends Biochem. Sci. 2006, 31:26-34.
29. Papa S., De Rasmo D., Scacco S., Signorile A., Technikova-Dobrova Z., Palmisano G., Sardanelli A.M., Papa F., Panelli D., Scaringi R., Santeramo A. Mammalian complex I: a regulable and vulnerable pacemaker in mitochondrial respiratory function. Biochim. Biophys. Acta 2008, 1777:719-728.
30. Paumard P., Vaillier J., Coulary B., Schaeffer J., Soubannier V., Mueller D.M., Brèthes D., di Rago J.P., Velours J. The ATP synthase is involved in generating mitochondrial cristae morphology. EMBO J. 2002, 21:221-230.
31. Rizzuto R., De Stefani D., Raffaello A., Mammucari C. Mitochondria as sensors and regulators of calcium signalling. Nat. Rev. Mol. Cell Biol. 2012, 13:566-578.
32. Sánchez-Aragó M., Chamorro M., Cuezva J.M. Selection of cancer cells with repressed mitochondria triggers colon cancer progression. Carcinogenesis 2010, 31:567-576.
33. Sánchez-Aragó M., Formentini L., Cuezva J.M. Mitochondria-mediated energy adaption in cancer: the H(+)-ATP synthase-geared switch of metabolism in human tumors. Antioxid. Redox Signal. 2013, 19:285-298.
34. Sánchez-Aragó M., Formentini L., Martínez-Reyes I., García-Bermudez J., Santacatterina F., Sánchez-Cenizo L., Willers I.M., Aldea M., Nájera L., Juarránz A., et al. Expression, regulation and clinical relevance of the ATPase inhibitory factor 1 in human cancers. Oncogenesis 2013, 2:e46.
35. Sánchez-Aragó M., García-Bermúdez J., Martínez-Reyes I., Santacatterina F., Cuezva J.M. Degradation of IF1 controls energy metabolism during osteogenic differentiation of stem cells. EMBO Rep. 2013, 14:638-644.
36. Sánchez-Cenizo L., Formentini L., Aldea M., Ortega A.D., García-Huerta P., Sánchez-Aragó M., Cuezva J.M. Up-regulation of the ATPase inhibitory factor 1 (IF1) of the mitochondrial H+-ATP synthase in human tumors mediates the metabolic shift of cancer cells to a Warburg phenotype. J. Biol. Chem. 2010, 285:25308-25313.
37. Schaar C.E., Dues D.J., Spielbauer K.K., Machiela E., Cooper J.F., Senchuk M., Hekimi S., Van Raamsdonk J.M. Mitochondrial and cytoplasmic ROS have opposing effects on lifespan. PLoS Genet. 2015, 11:e1004972.
38. Sharma K., D'Souza R.C., Tyanova S., Schaab C., Wiśniewski J.R., Cox J., Mann M. Ultradeep human phosphoproteome reveals a distinct regulatory nature of Tyr and Ser/Thr-based signaling. Cell Rep. 2014, 8:1583-1594.
39. Steinberg S.F., Brunton L.L. Compartmentation of G protein-coupled signaling pathways in cardiac myocytes. Annu. Rev. Pharmacol. Toxicol. 2001, 41:751-773.
40. Valsecchi F., Ramos-Espiritu L.S., Buck J., Levin L.R., Manfredi G. cAMP and mitochondria. Physiology (Bethesda) 2013, 28:199-209.
41. Vives-Bauza C., Yang L., Manfredi G. Assay of mitochondrial ATP synthesis in animal cells and tissues. Methods Cell Biol. 2007, 80:155-171.
42. Walker J.E. The ATP synthase: the understood, the uncertain and the unknown. Biochem. Soc. Trans. 2013, 41:1-16.
43. Wright P.E., Dyson H.J. Intrinsically disordered proteins in cellular signalling and regulation. Nat. Rev. Mol. Cell Biol. 2015, 16:18-29.
44. Yun J., Finkel T. Mitohormesis. Cell Metab. 2014, 19:757-766.
45. Zhao X., León I.R., Bak S., Mogensen M., Wrzesinski K., Højlund K., Jensen O.N. Phosphoproteome analysis of functional mitochondria isolated from resting human muscle reveals extensive phosphorylation of inner membrane protein complexes and enzymes. Mol. Cell Proteomics 2011, 10. M110.000299.
46. Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J., Mohammed S. Toward a comprehensive characterization of a human cancer cell phosphoproteome. J. Proteome Res. 2013, 12:260-271.